Immune System Booster - Hi-Tech Pharmaceuticals Pine Bark
If you're looking for a new & improved Immune System booster, look no further. Hi-Tech Pharmaceuticals Pine Bark is perfect for supporting your Immune System, Brain, & Cardiovascular health! Each serving of Hi-Tech Pharmaceuticals Pine Bark contains a whopping 200 milligrams of Pine Bark per serving & also may aid in fighting Oxidative Stress. Try it out today!! Introducing Hi-Tech Pharmaceuticals Pine Bark!!
Hi-Tech Pharmaceuticals Pine Bark Benefits
- Contains 200mg Of Pine Bark Per Serving
- Supports Good Cardiovascular Health
- Aids In Fighting Oxidative Stress
- Helps To Fight Cold & Flu Viruses
- May Boost Athletic Performance
- Helps To Boost Overall Brain Function
How Do I Take Hi-Tech Pharmaceuticals Pine Bark?
Hi-Tech Pharmaceuticals recommends taking 1 or 2 tablets daily, preferably at mealtimes.
Hi-Tech Pharmaceuticals Pine Bark Ingredients
Serving Size: 1 Tablet
Servings Per Container: 60
Tablets French Maritme Pine Bark 200mg Extract (Pinus Pinaster) (85% To 95% Proanthocyanidins)
Other Ingredients: Cyclosome Technology With Phospholipids From Non-GMO Soy Lecithin, Phophatidylcholine, Lysophosphatidylcholine, Phosphatidylethanolamine, Hydroxypropyl-B Cyclodextrin (HPBCD), Phytosterol 90% Complex, Microcrystalline Cellulose, Colloidal Silica Anhydrous, Magnesium Stearate.
Hi-Tech Pharmaceuticals Pine Bark Side Effects & Warnings
Not intended for use by person under 18 years of age. Keep out of reach of children. If you are pregnant, breast feeding, or have a known medical condition or are taking prescription or OTC medications consult with your Health Care Practitioner prior to using this product.
References
Iravani S, Zolfaghari B. Pharmaceutical and nutraceutical effects of Pinus pinaster bark extract. Res Pharm Sci. 2011;6(1):1–11.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203267/
Windmuller-Campione MA, Long JN. Limber Pine (Pinus flexilis James), a Flexible Generalist of Forest Communities in the Intermountain West. PLoS One. 2016;11(8):e0160324. Published 2016 Aug 30. doi:10.1371/journal.pone.0160324
